Neobiomics

21 April – Expert Webinar Highlights & Live Discussion British Hospital Experiences: Safety, Cost Benefits and Use of Probiotics in Neonatal Care Educational Event by Neobiomics Continuing our Expert Webinar Highlights & Live Discussion series, we invite you to join the second session, focused on clinical experiences with probiotics in neonatal care. The webinar will cover safety profiles, cost-effectiveness, and quality improvement strategies observed in UK neonatal units. Featuring pre-recorded presentations by leading neonatologists and a live Q&A moderated by Dr. Stefan Johansson, this session offers practical, evidence-based guidance for optimizing probiotic use in neonatal practice. Date: 21 April 2026 Time: 15:30 – 16:30 CET Location: Online (Teams Platform) What to expect · First-hand clinical experiences from doctors using ProPrems. · Review of clinical outcomes, safety considerations, and cost benefits observed in hospital practice. · Moderated discussion and audience Q&A, allowing participants to explore clinical implications and share best practices. Agenda 15:30 – Welcome and Introduction – Dr. Stefan Johansson 15:35 – Probiotics Experience and Cost Benefits of ProPrems at Imperial College Healthcare NHS Trust, London, UK – Dr. Aniko Deierl, Consultant Neonatologist (pre-recorded) 15:45 – Probiotics Quality Improvement Project as Part of a Multidisciplinary Care Bundle, Lancashire, UK – Dr. Richa Gupta, Consultant Neonatologist (pre-recorded) 15:55 – Live Discussion and Audience Q&A 16:15 – Closing Remarks – Dr. Stefan Johansson This session is intended for healthcare professionals seeking to understand the practical implementation, safety, and clinical outcomes of probiotics in neonatal care. Registration is limited to ensure an interactive experience. Reserve your place today. Register Here We look forward to your participation. Best regards, The Neobiomics Team

14 April – Expert Webinar Highlights & Live Discussion ARA & DHA Supplementation in Extremely Preterm Infants Scientific Evidence and Clinical Experiences of NeoMega36® Educational Event by Neobiomics We are pleased to introduce our new Expert Webinar Highlights & Live Discussion series and invite you and your colleagues to join the first session, focusing on ARA and DHA supplementation in extremely preterm infants. This session will review key clinical studies and findings through curated pre-recorded expert presentations, followed by interactive discussion and live Q&A moderated by Dr. Stefan Johansson. Date: 14 April 2026 Time: 15:30 – 16:10 CET Location: Online (Teams Platform) What to expect • Presentation of data from the Mega Donna Mega trial and associated substudies, forming the scientific basis for NeoMega36®. • Overview of NeoMega36®, an enteral lipid supplement containing arachidonic acid (ARA) and docosahexaenoic acid (DHA), designed to support normal visual development in extremely preterm infants. • Moderated discussion and audience Q&A, enabling participants to explore clinical implications and practical applications. Agenda 15:30 – Welcome - Dr. Stefan Johansson 15:35 – Introduction to NeoMega36® – Dr. Stefan Johansson 15:40 – Mega Donna Mega trial and substudies – Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomised Clinical Trial Prof. Ann Hellström, Professor of Pediatric Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Sweden (pre-recorded presentation) 15:55 – Live discussion and audience Q&A 16:10 – Closing remarks - Dr. Stefan Johansson This session is intended for healthcare professionals seeking to examine current evidence on ARA and DHA supplementation in extremely preterm infants and to discuss practical considerations in clinical care. Registration is limited to ensure an interactive experience. Reserve your place today. ⁠Register Here We look forward to your participation. Best regards, The Neobiomics Team

Register for the webinar here: https://us06web.zoom.us/meeting/register/fAHaXREDSP2h3RqKMbnq4Q Scientific Webinar by Neobiomics We are excited to invite you to our exclusive autumn webinar session, where leading neonatologists will discuss their clinical experiences with probiotics. DATE: 18 November 2025 TIME: 16.30-17.30 CET What to expect: · Prof. Dr. Christoph Härtel, Head of the Pediatric Department at University Hospital Würzburg, will share his team’s experience with probiotics in neonatal care — from early implementation to clinical outcomes. He will highlight key learnings, clinical results, and practical insights from their NICU experience. · Dr. Adam Reynolds and his team recently presented a poster on their NICU’s experience with probiotics at the BAPM British Association of Perinatal Medicine Conference in September 2025. In this webinar, Dr. Reynolds will share insights from the first year of implementation, highlighting both the clinical outcomes and the cost aspects of introducing probiotics in neonatal care. · Connect with fellow neonatology professionals around Europe, learn from each other and share best practices! AGENDA: 16:30: Welcome and Introduction – Dr. Stefan Johansson 16:35: Experience of Probiotics in the NICU at University Hospital Würzburg, Germany - Prof. Dr. Christoph Härtel, Head of the Pediatric Department 16:45: Clinical and Cost Insights 1 Year After Implementation at Royal Jubilee Maternity Hospital, Belfast Health and Social Care Trust - Dr. Adam Reynolds, MRCPCH PhD, Consultant Neonatologist 17:00: Q&A 17:25: Closing Remarks - Dr. Stefan Johansson Seats are limited, so don’t miss out on this opportunity! Register for the webinar here: https://us06web.zoom.us/meeting/register/fAHaXREDSP2h3RqKMbnq4Q We look forward to your participation! Best regards, Neobiomics Team

Neobiomics is pleased to invite you to the upcoming NeoMega36® Webinar, where leading experts in neonatology will share the latest scientific evidence and clinical experiences on ARA and DHA supplementation in extremely preterm infants. Date: 12 November 2025 Time: 15.30 – 16.30 CET Register Here: https://us06web.zoom.us/meeting/register/JxHc93kdQ9yTDmyUc8QUbA Topic: ARA & DHA Supplementation in Extremely Preterm Infants- Clinical Experiences of NeoMega36® from 2 Europen NICUs What to expect: Dr. Norbert Teig will provide an overview of nearly two years of clinical experience using ARA and DHA supplementation in extremely preterm infants in his German NICU. He will discuss the rationale for implementing this approach, share observed outcomes, and highlight key learnings and practical insights from everyday clinical practice. Dr. Jiří Dušek will present one year of clinical experience with ARA and DHA supplementation in his Czech NICU. He will describe the implementation process, review clinical outcomes, and share the practical insights and lessons learned from incorporating this intervention into routine neonatal care. Introduction to NeoMega36® – supporting the normal vision development in extremely preterm infants, an innovative solution containing arachidonic acid (ARA) and docosahexaenoic acid (DHA). Agenda: 15:30: Welcome and Introduction of NeoMega36®– Dr. Stefan Johansson 15:40: German Clinical Experience: Building Experience with ARA and DHA: Nearly Two Years Supporting Visual Development in Extremely Preterm Infants - Dr. Norbert Teig, Consultant Neonatologist, Department of Pediatrics and Adolescent Medicine, Catholic Hospital Bochum, Germany 15:50: Insights from the Czech Republic: Implementing ARA and DHA Supplementation: One Year of Clinical Experience in a Czech NICU- Dr. Jiří Dušek, Head of the Department of Neonatology, České Budějovice Hospital, Czech Republic 16:00: Discussion - All 16:15: Closing Remarks - Dr. Stefan Johansson Don’t miss out – join our expert-led discussion on ARA & DHA and their impact on vision development in extremely preterm infants! Register Here: https://us06web.zoom.us/meeting/register/JxHc93kdQ9yTDmyUc8QUbA We look forward to your participation! Best regards, Team Neobiomics

Neobiomics and 99NICU are pleased to invite you to the upcoming NeoMega36® Webinar, where leading experts in neonatology and ophthalmology will share the latest scientific evidence and clinical experiences on ARA and DHA supplementation in extremely preterm infants. Date: 14 October 2025 Time: 15.30 – 16.30 CET Register Here: https://us06web.zoom.us/meeting/register/-o0RnQR3S_arS5EfX6Zs9A Topic: ARA & DHA Supplementation in Extremely Preterm Infants- Scientific Evidence and Clinical Experiences of NeoMega36® What to expect: Prof. Ann Hellström will present findings from the Mega Donna Mega trial and its substudies, key research that contributed to the development of NeoMega36®. Dr. Jiří Dušek, one of the first users of NeoMega36®, will share his experiences, explain why his team decided to implement it their NICU, and discuss outcomes and key learnings after one year of practical use. Introduction to NeoMega36® – supporting the normal vision development in extremely preterm infants, an innovative solution containing arachidonic acid (ARA) and docosahexaenoic acid (DHA). Speakers: Prof. Ann Hellström Mega Donna Mega Trial and its substudies Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomised Clinical Trial Professor of Pediatric Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Sweden Dr. Jiří Dušek First-Year Experience from Our NICU ARA and DHA Supplementation to Support Normal Visual Development in Extremely Premature Infants Head of the Department of Neonatology, Hospital Nemocnice České Budějovice, Czech Republic Dr. Stefan Johansson Moderator Chief Medical Officer & Co-founder at Neobiomics Associate Professor and Consultant Neonatologist at Sachsska University Hospital, Stockholm, Sweden Don’t miss out – join our expert-led discussion on ARA & DHA and their impact on vision development in extremely preterm infants! Register Here: https://us06web.zoom.us/meeting/register/-o0RnQR3S_arS5EfX6Zs9A We look forward to your participation! Best regards, Team Neobiomics

Webinar: Belfast Trust NICU Experience with Probiotics: One Year of Clinical and Cost Insights Scientific Webinar by Neobiomics We are excited to invite you to our exclusive autumn webinar session, where leading neonatologists will discuss their clinical experiences with probiotics. DATE: 2 October TIME: 16.00-16.40 CET WHAT TO EXPECT: Dr. Adam Reynolds and his team recently presented a poster on their NICU’s experience with probiotics at the BAPM British Association of Perinatal Medicine Conference in September 2025. In this webinar, Dr. Reynolds will share insights from the first year of implementation, highlighting both the clinical outcomes and the cost aspects of introducing probiotics in neonatal care. Connect with fellow neonatology professionals around Europe, learn from each other and share best practices! REGISTER HERE: https://us06web.zoom.us/meeting/register/DeSX3jTORtm1ttFbvS0Z1w AGENDA: 16.00: Welcome and Introduction – Dr. Stefan Johansson 16.05: probiotics experience at Royal Jubilee Maternity Hospital, Belfast Health and Social Care Trust - Dr. Adam Reynolds, MRCPCH PhD, Consultant Neonatologist 16.20: Q&A 16.35: Closing Remarks - Dr. Stefan Johansson Seats are limited, so don’t miss out on this opportunity! REGISTER HERE: https://us06web.zoom.us/meeting/register/DeSX3jTORtm1ttFbvS0Z1w We look forward to your participation! Best regards, Neobiomics Team (Note: This event is exclusively for healthcare professionals and official partners.)